Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKCA | INBX | GLPG | ||
| Company | Akcea Therapeutics Inc | Inhibrx Biosciences Inc | Galapagos NV ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.15 | 127.99 | 27.88 | ||
| High | 18.17 | 134.40 | 28.56 | ||
| Low | 18.13 | 127.99 | 27.73 | ||
| Latest | 18.17 | 129.45 | 28.45 | ||
| Change | +0.03 | +0.66 | +0.45 | ||
| % Change | +0.17% | +0.51% | +1.61% | ||
| Volume | 815,300 | 403,546 | 276,444 | ||
| 20-Day Average Volume | 661,490 | 524,982 | 142,902 | ||
| Previous Close | 18.14 | 128.79 | 28.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.14 | 100.18 | 28.66 | ||
| 20-Day Raw Stochastic | 70.59% | 75.48% | 50.26% | ||
| 20-Day Relative Strength | 73.10 | 74.70 | 40.38 | ||
| Weighted Alpha | -23.90 | +411.13 | +1.06 | ||
| Today's Opinion | 72% Buy | 100% Buy | 100% Sell | ||
| Previous Opinion | 64% Buy | 100% Buy | 100% Sell | ||
| Last Month's Opinion | 8% Buy | 24% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 10/02/20 | +0.42% since 04/27/26 | unch since 04/27/26 | ||
| Low | 18.08 on 10/05/20 | 122.61 on 04/30/26 | 27.49 on 04/29/26 | ||
| High | 18.17 on 10/09/20 | 134.40 on 05/04/26 | 28.71 on 04/28/26 | ||
| 1-Month | |||||
| %Chg | +0.17% since 09/09/20 | +107.78% since 04/02/26 | -3.23% since 04/02/26 | ||
| Low | 18.05 on 09/21/20 | 60.33 on 04/07/26 | 27.49 on 04/29/26 | ||
| High | 18.22 on 09/28/20 | 155.29 on 04/22/26 | 29.77 on 04/06/26 | ||
| 3-Month | |||||
| %Chg | +36.72% since 07/09/20 | +59.88% since 02/04/26 | -17.79% since 02/04/26 | ||
| Low | 9.81 on 08/05/20 | 57.30 on 03/27/26 | 27.49 on 04/29/26 | ||
| High | 19.65 on 08/31/20 | 155.29 on 04/22/26 | 36.24 on 02/24/26 | ||
| 6-Month | |||||
| %Chg | +11.88% since 04/09/20 | +61.00% since 11/04/25 | -6.53% since 11/04/25 | ||
| Low | 9.81 on 08/05/20 | 57.30 on 03/27/26 | 27.49 on 04/29/26 | ||
| High | 19.65 on 08/31/20 | 155.29 on 04/22/26 | 36.24 on 02/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,846,054 | 1,881,236 | 1,845,116 | ||
| Shares Outstanding, K | 101,599 | 14,607 | 65,897 | ||
| Annual Sales | 488,540,000 | 1,300,000 | 1,258,400,000 | ||
| Annual Net Income | 40,770,000 | -140,060,000 | 363,050,000 | ||
| Last Quarter Sales | 22,380,000 | 0 | 78,990,000 | ||
| Last Quarter Net Income | -49,580,000 | -35,260,000 | -161,610,000 | ||
| 60-Month Beta | 1.45 | 3.87 | 0.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 08/04/20 | -2.11 on 03/19/26 | N/A | ||
| Earnings Date | 11/03/20 | 05/13/26 | 05/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||